玻璃体内注射贝伐单抗或曲安奈德治疗糖尿病性黄斑弥漫性水肿。 - Suppr

Suppr

超能文献

Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.

作者信息

Rensch Florian, Spandau Ulrich H M, Wickenhäuser Anne, Jonas Jost B

出版信息

Acta Ophthalmol. 2010 Mar;88(2):e36-7. doi: 10.1111/j.1755-3768.2008.01443.x.

DOI:10.1111/j.1755-3768.2008.01443.x

PMID:19210330

Abstract

摘要

相似文献

Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.玻璃体内注射贝伐单抗或曲安奈德治疗糖尿病性黄斑弥漫性水肿。

Acta Ophthalmol. 2010 Mar;88(2):e36-7. doi: 10.1111/j.1755-3768.2008.01443.x.

Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗与曲安奈德治疗持续性弥漫性糖尿病性黄斑水肿的疗效比较评估

Am J Ophthalmol. 2008 Dec;146(6):974; author reply 974-5. doi: 10.1016/j.ajo.2008.08.013.

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).玻璃体内注射曲安奈德与贝伐单抗治疗难治性糖尿病性黄斑水肿（IBEME研究）

Br J Ophthalmol. 2008 Jan;92(1):76-80. doi: 10.1136/bjo.2007.129122. Epub 2007 Oct 26.

Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.比较玻璃体内曲安奈德和贝伐单抗注射治疗糖尿病黄斑水肿：一项随机双盲研究。

Acta Ophthalmol. 2012 Feb;90(1):56-60. doi: 10.1111/j.1755-3768.2009.01817.x. Epub 2009 Dec 16.

Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.单次玻璃体内注射贝伐单抗与曲安奈德作为弥漫性糖尿病性黄斑水肿主要治疗方法的比较

Acta Ophthalmol. 2012 Mar;90(2):e160-1. doi: 10.1111/j.1755-3768.2010.02098.x. Epub 2011 Apr 6.

Am J Ophthalmol. 2008 May;145(5):854-61. doi: 10.1016/j.ajo.2007.12.031. Epub 2008 Mar 6.

Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.玻璃体内曲安奈德与玻璃体内联合贝伐单抗和地塞米松治疗弥漫性糖尿病黄斑水肿。

Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):673-81. doi: 10.1111/j.1442-9071.2011.02504.x. Epub 2011 Mar 24.

Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.玻璃体腔内注射贝伐单抗联合后Tenon囊下注射曲安奈德治疗糖尿病性黄斑水肿

Acta Ophthalmol. 2014 Nov;92(7):e589-90. doi: 10.1111/aos.12420. Epub 2014 May 27.

Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema.比较网格激光、玻璃体内曲安奈德和玻璃体内贝伐单抗治疗弥漫性糖尿病性黄斑水肿。

Ophthalmologica. 2012;227(2):95-9. doi: 10.1159/000331322. Epub 2011 Sep 2.

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.玻璃体内注射贝伐单抗（阿瓦斯汀）对慢性弥漫性糖尿病性黄斑水肿患者的长期影响。

Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48.

引用本文的文献

Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema-Systematic review, meta-analysis and meta-regression.玻璃体内贝伐单抗与玻璃体内曲安奈德治疗糖尿病性黄斑水肿的比较-系统评价、荟萃分析和荟萃回归。

PLoS One. 2021 Jan 12;16(1):e0245010. doi: 10.1371/journal.pone.0245010. eCollection 2021.

Comparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema.玻璃体内注射贝伐单抗与曲安奈德治疗弥漫性糖尿病性黄斑水肿的比较。

Int J Ophthalmol. 2015 Jun 18;8(3):550-5. doi: 10.3980/j.issn.2222-3959.2015.03.20. eCollection 2015.

Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis.玻璃体内注射曲安奈德与玻璃体内注射贝伐单抗治疗糖尿病性黄斑水肿的荟萃分析

Int J Ophthalmol. 2013 Aug 18;6(4):546-52. doi: 10.3980/j.issn.2222-3959.2013.04.26. eCollection 2013.

Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema.曲安奈德单次注射与贝伐单抗三次重复注射治疗糖尿病性黄斑水肿的比较

Int Ophthalmol. 2013 Aug;33(4):375-80. doi: 10.1007/s10792-012-9709-z. Epub 2013 Jan 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验